Skip to main content

Table 1 The clinical characteristics of the 124 men who received radical local therapy

From: Pre-treatment 18F-choline PET/CT is prognostic for biochemical recurrence, development of bone metastasis, and cancer specific mortality following radical local therapy of high-risk prostate cancer

Age, yrs

 Mean (SD)

66.4 (6.1)

PSA, ng/ml

 

 Median (IQR)

22 (11–36)

Biopsy Gleason Score, n (%)

 3 + 3

9 (7)

 3 + 4

25 (20)

 4 + 3

16 (13)

 4 + 4/3 + 5/5 + 3

30 (24)

 4 + 5/5 + 4/5 + 5

44 (36)

Clinical tumor stage, n (%)

 Tx

1 (1)

 T1

28 (23)

 T2

44 (36)

 T3

51 (41)

18F-choline PET/CT, n (%)

 Negative

97 (78)

 Inconclusive

15 (12)

 Positive

12 (10)

Local therapy

 Radical prostatectomy

28 (23)

 Radiation therapy

96 (77)

  1. Abbreviations: SD standard deviation, PSA prostate specific antigen, IQR inter-quartile range, PET/CT positron emission tomography fused with computed tomography